Other Illnesses, Body Weight Do Not Explain Racial Disparities in Colon Cancer Survival, UAB Researchers SayNovember 24, 2009BIRMINGHAM, Ala. - A new study by University of Alabama at Birmingham (UAB) researchers shows that body-mass index (BMI) and co-existing medical conditions (co-morbidity) do not explain the decreased survival observed among African-Americans compared to Caucasians who also have colon cancer. The study is published online Nov. 23 in Cancer, a journal of the American Cancer Society. The finding indicates that although BMI and co-morbidity are independent predictors of poor survival for all patients, these factors do not explain the increased risk of death associated with African-Americans. "Therefore, more research is needed to gain a fuller understanding of how race and ethnicity are involved in colon cancer survival following surgery," says Upender Manne, Ph.D., an associate professor in the UAB Department of Pathology and the lead study author. For many cancers, including colon cancer, African-Americans have lower survival rates than whites; possible reasons behind this disparity - including genetic variation, tumor characteristics, access to health care and other factors - are being examined extensively, Manne says. There was a belief that racial disparity in survival following surgery for colon cancer was related to a high BMI and co-morbidity. BMI is a numerical value of weight in relation to height; obesity is defined as a BMI of 30 or more. The UAB researchers analyzed data from 496 patients who underwent surgery for colon cancer at UAB Hospital between 1981 and 2002. Until the end of the study in 2008, the researchers looked at factors such as BMI, co-morbidity, demographics and tumor properties as they relate to survival rates. The analysis revealed that African-Americans were 34 percent more likely to have died by the end of the study than Caucasians. Among patients with advanced stages of cancer, being underweight increased the risk of death by 87 percent. Being overweight or obese was protective in patients with Stage IV disease and decreased the risk of death by 42 percent. "That was the surprising finding for us - that a high BMI was actually protective in patients with advanced-stage disease," Manne says. "Co-morbidity in cancer can have an important role, we know, because it impacts everything from the timing of diagnosis to treatment decisions. Obviously, BMI and co-morbidity are not the answers we need to explain the survival disparity in colon cancer. Something else is going on." The research is a collaborative effort between Manne and the UAB departments of Epidemiology, Preventive Medicine, Biostatistics and the UAB School of Medicine. About the UAB Department of Pathology The UAB Department of Pathology provides extensive clinical services and teaching while maintaining large and productive research programs. Its clinical services - including inpatient, outpatient and outreach - encompass more than 6 million procedures per year. UAB's pathology training programs are among the finest in the country, and its faculty has achieved national and international recognition in service, teaching, and research. University of Alabama at Birmingham |
|||||||||||||||||||||
| Related Colon Cancer Current Events and Colon Cancer News Articles High vitamin D levels linked to lower risk of colon cancer High blood levels of vitamin D are associated with a lower risk of colon cancer, finds a large European study published on bmj.com today. The risk was cut by as much as 40% in people with the highest levels compared with those in the lowest. The first map of colon cancer in Spain is published There are stark geographical contrasts in the incidence of colon cancer worldwide. The new study analyses the causes of these disparities, starting with Spanish trends between 1951 and 2006 in terms of certain changes in consumption (tobacco, alcohol, red and processed meat, fish, vegetables...) and also behaviour (physical exercise, sedentary lifestyles-). Pitt researchers raise concern over frequency of surveillance colonoscopy How often patients receive surveillance colonoscopy may need to be better aligned with their risks for colorectal cancer, according to two papers published this month by University of Pittsburgh School of Medicine researchers. New biomarkers for predicting the spread of colon cancer Scientists in China are reporting discovery of two proteins present in the blood, of people with colon cancer that may serve as the potential biomarkers for accurately predicting whether the disease will spread. Their study is in ACS' Journal of Proteome Research, a monthly publication. Does electro-acupuncture prevent prolonged postoperative ileus? A research article to be published on January 7 , 2010 in the World Journal of Gastroenterology addresses this question. In this prospective randomized clinical trial, the authors examined if acupuncture could prevent prolonged postoperative ileus (PPOI) after intraperitoneal surgery among patients with colon cancer in Shanghai, China. Mango effective in preventing, stopping certain colon, breast cancer cells Mango. If you know little about this fruit, understand this: It's been found to prevent or stop certain colon and breast cancer cells in the lab. New hope for therapy in heartburn-related cancer Cancer of the gullet, or oesophagus, is one of the ten most common cancers in the Western world, and there have been recent alarming increases in the number of cases each year in the US and UK. New England Journal of Medicine publishes CWRU review of the 'molecular basis of colorectal cancer' Every year in the United States, 160,000 cases of colorectal cancer are diagnosed, and 57,000 patients die of the disease, making it the second leading cause of death from cancer among adults, after lung cancer. Heart drugs show promise for fighting colon cancer Scientists in Sweden are reporting for the first time that a group of drugs used to treat heart failure shows promise for fighting colon cancer. UGA Study finds significantly worse outcomes in cancer patients with cognitive impairment A new study published by researchers from the University of Georgia and the Moffitt Cancer Center in Tampa, Fla., has found that cancer patients with dementia have a dramatically lower survival rate than patients with cancer alone, even after controlling for factors such as age, tumor type and tumor stage. More Colon Cancer Current Events and Colon Cancer News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||